Email updates

Keep up to date with the latest news and content from Genome Biology and BioMed Central.

Open Badges Research news

Oncogenic phosphatase amplification

Jonathan B Weitzman

Genome Biology 2002, 3:spotlight-20020523-01  doi:10.1186/gb-spotlight-20020523-01

The electronic version of this article is the complete one and can be found online at:

Published:23 May 2002

© 2002 BioMed Central Ltd

Research news

Post-translational regulation of p53 regulates its activity and tumour suppressor functions. In an Advanced Online Publication in Nature Genetics, Bulavin et al. from the National Institutes of Health describe how oncogenic Ras regulates p53 phosphorylation (Nature Genetics 20 May 2002, DOI:10.1038/ng894). Using antibodies specific for different modified forms of p53 they showed that oncogenic Ras induced p53, accumulation and phosphorylation of two specific serine residues that are substrates of p38 MAP kinase Bulavin et al. found that the p53-inducible phosphatase PPM1D abrogates p53 phosphorylation indirectly by inhibiting MAP kinase activity; overexpression of PPM1D was oncogenic in p53-expressing cells. They found evidence for amplification and overexpression of the human PPM1D gene in breast cancer cells expressing wild-type p53. An accompanying report by Li et al. provides additional evidence for PPM1D locus amplification and overexpression in breast cancer cells (Nature Genetics 20 May 2002, DOI:10.1038/ng888). These results suggest that amplification of the chromosome 17q22/24 region containing the PPM1D gene suppresses p53 function by regulating post-translational modification.


  1. Post-translational modifications and activation of p53 by genotoxic stresses.

    PubMed Abstract | Publisher Full Text OpenURL

  2. [] webcite

    Nature Genetics

  3. [] webcite

    National Institutes of Health

  4. Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation.

    PubMed Abstract | Publisher Full Text OpenURL